ELVN

Enliven TherapeuticsD

Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences

At close

2026-07-20

View Chart

RSI (14)

59.0

Neutral

MACD Hist

-0.15

Bearish

ATR (14)

2.63

Normal

Vol Z (20)

-0.74

Normal

RET 20D

+12.4%

Positive

Dist 52W High

-2.9%

Near High

Technical chart

1 Year

Candles, moving averages, and volume using the current RankAlpha theme.

As of 2026-07-20

Price

SMA 20

SMA 50

SMA 200

Trend readout

Technical readout

Trend

Uptrend (SMA20 > SMA50 > SMA200)

Momentum

Positive momentum · 20D +12.4% · 60D +17.7%

RSI / MACD

RSI 59.0 (Neutral) · MACD hist -0.15

Volatility

Volatility normal (Z -0.74)

SMA20

50.41

SMA50

44.32

SMA200

31.31

EMA12

51.11

EMA26

48.75

BB Upper

53.83

BB Mid

50.41

BB Lower

46.99

RET 5D

-0.1%

RET 20D

+12.4%

RET 60D

+17.7%

RET 120D

+97.5%

As of 2026-07-20 • Updated nightlySource: Internal modelMethodology